Med Polonia Sp. z o.o.

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of lung cancer. The center's work in this field is characterized by its exploration of novel therapeutic combinations and targeted therapies.

• Extensive-stage small-cell lung cancer
• Non-small cell lung cancer (NSCLC)
• Renal cell carcinoma

By integrating cutting-edge research with clinical practice, the center is advancing the understanding and treatment of complex cancer types, offering hope for improved patient outcomes.

Specializing in neurology, the center is dedicated to advancing the treatment of neurological disorders, with a particular focus on multiple sclerosis. The research conducted here aims to enhance the safety and efficacy of emerging therapies.

• Relapsing forms of multiple sclerosis
• Relapsing-remitting multiple sclerosis

Through rigorous clinical trials, the center is contributing to the development of new therapeutic strategies that aim to improve the quality of life for patients with neurological conditions.

The center's immunology research is focused on understanding and treating autoimmune diseases, with a particular emphasis on Sjögren's syndrome. This research is pivotal in developing therapies that target the underlying mechanisms of immune dysfunction.

• Sjögren's syndrome

By exploring novel immunomodulatory treatments, the center is paving the way for more effective management of autoimmune diseases, enhancing patient care and outcomes.

In the field of endocrinology, the center is pioneering research into the treatment of diabetic complications, particularly focusing on innovative approaches to healing diabetic foot ulcers.

• Diabetic foot ulcers

The center's research efforts are directed towards developing topical treatments that promote wound healing, thereby reducing the risk of severe complications and improving patient quality of life.